MoS2@Ti3C2 nanohybrid-based photoelectrochemical biosensor: A platform for ultrasensitive detection of cancer biomarker exosomal miRNA

Zhiwei Sun,Yao Tong,Li Zhao,Juan Li,Fucheng Gao,Chuanxin Wang,Hui Li,Lutao Du,Yanyan Jiang
DOI: https://doi.org/10.1016/j.talanta.2021.123077
IF: 6.1
2022-02-01
Talanta
Abstract:As a class of newly identified biomarkers, miRNAs show enormous potential in cancer diagnosis. The sensitive detection of abnormal miRNAs concentration to realize early diagnosis of malignant tumors is a frontier in the field of biosensing. In this work, a photoelectrochemical (PEC) biosensor based on MoS<sub>2</sub>@Ti<sub>3</sub>C<sub>2</sub> nanohybrid was fabricated for the ultrasensitive detection of miRNAs. The hybridization of Ti<sub>3</sub>C<sub>2</sub> with excellent electron transfer capability significantly enhances the photocurrent response of the PEC biosensor. Moreover, the electrodeposition of Au nanoparticles on the surface of MoS<sub>2</sub>@Ti<sub>3</sub>C<sub>2</sub> nanohybrid further enhances the photocurrent. The detection performance of the PEC biosensor has been tested using colorectal cancer-related exosomal miRNA (miR-92a-3p) as the target. The PEC biosensor shows a broad linear detection ranged from 1 fM to 100 nM and a calculated detection limit of 0.27 fM. In terms of selectivity, the PEC biosensor can distinguish miR-92a-3p from mismatched sequences. The 16 continuous radiation source on-off cycles test indicates the high stability of the PEC biosensor. Furthermore, the accurate detection of exosomal miR-92a-3p concentrations of patients and healthy controls demonstrates the clinical feasibility of the PEC biosensor. Based on these outcomes, the PEC biosensor exhibits the prospect of realizing the ultrasensitive point-of-care detection of miRNAs.
chemistry, analytical
What problem does this paper attempt to address?